Michael Schrader

Michael Schrader is the founder and former CEO of Vaxess, a clinical-stage company bringing healthcare out of the clinic and into patients’ lives with the MIMIX patch platform. Vaxess is building a pipeline of transformational home-based products, including a recently announced mRNA partnership with Astra Zeneca. The company has raised more than $90M in grant and VC funding from groups such as RA Capital, The MIT Engine, BARDA, NIH, and The Gates Foundation. Michael has served as an advisor to several startups including Bytesense, Ally Therapeutics and Adeo Health Sciences. He also serves as an Expert-In-Residence at the Harvard Office of Technology Development and as a Key Advisory Board Member for the Harvard Blavatnik Fellowship program. Prior to Vaxess, Michael spent time at Google and Honda where he helped bring a range of products to market and earned more than fifteen patents. Michael received his B.S. in Mechanical Engineering from Purdue University and his M.B.A. from Harvard.